# Paraneoplastic Dermatomyositis as the Presenting Symptom of Tonsillar Squamous Cell Carcinoma: A Case Report

**Authors:** Max Vogel, Abigail Kammerer, Raj Dwivedi, Karyn Dyehouse, Terese Howes

PMC · DOI: 10.7759/cureus.92974 · 2025-09-22

## TL;DR

A rare case shows that dermatomyositis can be the first sign of tonsillar cancer, highlighting the need for cancer screening in such patients.

## Contribution

Reports a rare case of p16+ tonsillar carcinoma presenting as paraneoplastic dermatomyositis.

## Key findings

- Dermatomyositis was the initial symptom of p16-positive squamous cell carcinoma of the oropharynx.
- The case involved unilateral neck involvement and a solitary lung metastasis.
- This highlights the importance of considering tonsillar carcinoma in dermatomyositis screening.

## Abstract

Dermatomyositis is an autoimmune multisystem disorder affecting skin and skeletal muscle that often presents with symmetric proximal muscle weakness and cutaneous manifestations such as rash. Dermatomyositis may present as a paraneoplastic phenomenon before, concurrent with, or after the diagnosis of cancer. Several cancers, including lung, breast, stomach, ovary, and kidney carcinoma, are frequently noted as the trigger for the development of paraneoplastic dermatomyositis. Less common, nasopharyngeal carcinomas have been associated with paraneoplastic dermatomyositis. Even more rare, we present a case of a 61-year-old male found to have dermatomyositis as the presenting symptom of p16-positive squamous cell carcinoma of the oropharynx involving the left tonsil with unilateral neck involvement and solitary lung metastasis. This case highlights a rare presentation of paraneoplastic dermatomyositis and emphasizes the importance of including p16+ tonsillar carcinoma in the differential diagnosis and screening protocols following the discovery of dermatomyositis.

## Linked entities

- **Proteins:** CDKN2A (cyclin dependent kinase inhibitor 2A)
- **Diseases:** dermatomyositis (MONDO:0016367), squamous cell carcinoma (MONDO:0005096), tonsillar carcinoma (MONDO:0021337)

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}
- **Diseases:** tonsillar carcinoma (MESH:D014067), Tonsillar Squamous Cell Carcinoma (MESH:D002294), lung metastasis (MESH:D009362), autoimmune multisystem disorder (MESH:D001327), nasopharyngeal carcinomas (MESH:D000077274), muscle weakness (MESH:D018908), rash (MESH:D005076), lung, breast, stomach, ovary, and kidney carcinoma (MESH:D061325), Dermatomyositis (MESH:D003882), cancer (MESH:D009369)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12547066/full.md

---
Source: https://tomesphere.com/paper/PMC12547066